Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases

Background Two-stage hepatectomy has been proposed for patients with bilateral colorectal liver metastases (CLM). The aim of this study was to compare the outcome of patients with CLM treated with preoperative chemotherapy followed by one- or two-stage hepatectomy. Methods From a prospective databas...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Chun, Yun Shin (author)
مؤلفون آخرون: Vauthey, Nicolas (author), Ribero, Dario (author), Donadon, Matteo (author), Mullen, John (author), Eng, Cathy (author), Madoff, David (author), Chang, David (author), Ho, Linus (author), Kopetz, Scott (author), Wei, Steven (author), Curley, Steven (author), Abdalla, Eddie (author)
التنسيق: article
منشور في: 2007
الوصول للمادة أونلاين:http://hdl.handle.net/10725/2555
http://dx.doi.org/10.1007/s11605-007-0272-2
http://link.springer.com/article/10.1007/s11605-007-0272-2
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513458633965568
author Chun, Yun Shin
author2 Vauthey, Nicolas
Ribero, Dario
Donadon, Matteo
Mullen, John
Eng, Cathy
Madoff, David
Chang, David
Ho, Linus
Kopetz, Scott
Wei, Steven
Curley, Steven
Abdalla, Eddie
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author_facet Chun, Yun Shin
Vauthey, Nicolas
Ribero, Dario
Donadon, Matteo
Mullen, John
Eng, Cathy
Madoff, David
Chang, David
Ho, Linus
Kopetz, Scott
Wei, Steven
Curley, Steven
Abdalla, Eddie
author_role author
dc.creator.none.fl_str_mv Chun, Yun Shin
Vauthey, Nicolas
Ribero, Dario
Donadon, Matteo
Mullen, John
Eng, Cathy
Madoff, David
Chang, David
Ho, Linus
Kopetz, Scott
Wei, Steven
Curley, Steven
Abdalla, Eddie
dc.date.none.fl_str_mv 2007
2015-11-12T13:31:22Z
2015-11-12T13:31:22Z
2015-11-12
dc.identifier.none.fl_str_mv 1091-255X
http://hdl.handle.net/10725/2555
http://dx.doi.org/10.1007/s11605-007-0272-2
Chun, Y. S., Vauthey, J. N., Ribero, D., Donadon, M., Mullen, J. T., Eng, C., ... & Abdalla, E. K. (2007). Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. Journal of Gastrointestinal Surgery, 11(11), 1498-1505.
http://link.springer.com/article/10.1007/s11605-007-0272-2
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Journal of Gastrointestinal Surgery
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases
Perioperative Safety and Survival
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Background Two-stage hepatectomy has been proposed for patients with bilateral colorectal liver metastases (CLM). The aim of this study was to compare the outcome of patients with CLM treated with preoperative chemotherapy followed by one- or two-stage hepatectomy. Methods From a prospective database, 214 consecutive patients who received preoperative systemic chemotherapy (fluoropyrimidine with irinotecan or oxaliplatin) followed by planned one- or two-stage hepatectomy were retrospectively analyzed (1998–2006). In patients undergoing two-stage procedures, minor hepatectomy (wedge or segmental resection[s]) was systematically performed before major (more than three segments), second-stage hepatectomy. Preoperative portal vein embolization (PVE) was performed if indicated. Results One- (group I) and two-stage(group II) hepatectomies were performed in 184 and 21 patients, respectively. Median number of metastases in groups I and II were two (range 1–20) and seven (range 2–20). All patients in group II had bilateral disease vs 39% in group I. Major hepatectomy was performed in all patients in group II and 79% in group I. PVE was performed in 18 group I and 12 group II patients without increase in morbidity. For group I, group II first stage, and group II second stage, respectively, morbidity (24%, 24%, 43%), median hospital stay (7 days, 6 days, 6.5 days) and 30 days postoperative mortality (2%, 0%, 0%) were not significantly different (P = NS). Median follow-up was 25 months; median survival has not been reached. One- and 3-year overall and disease-free survival rates from the time of hepatic resection were 95% and 75%, 63% and 39%, respectively in group I; 95% and 86%, 70% and 51%, respectively in group II (P = NS). Conclusions Two-stage hepatectomy with preoperative chemotherapy results in comparable morbidity and survival rates as one-stage hepatectomy. This approach enables selection and treatment of patients with multiple, bilateral CLM who will benefit from aggressive surgery with good outcomes.
eu_rights_str_mv openAccess
format article
id LAURepo_e0eddac176d4037cba7ed38c71df7cd7
identifier_str_mv 1091-255X
Chun, Y. S., Vauthey, J. N., Ribero, D., Donadon, M., Mullen, J. T., Eng, C., ... & Abdalla, E. K. (2007). Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. Journal of Gastrointestinal Surgery, 11(11), 1498-1505.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/2555
publishDate 2007
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver MetastasesPerioperative Safety and SurvivalChun, Yun ShinVauthey, NicolasRibero, DarioDonadon, MatteoMullen, JohnEng, CathyMadoff, DavidChang, DavidHo, LinusKopetz, ScottWei, StevenCurley, StevenAbdalla, EddieBackground Two-stage hepatectomy has been proposed for patients with bilateral colorectal liver metastases (CLM). The aim of this study was to compare the outcome of patients with CLM treated with preoperative chemotherapy followed by one- or two-stage hepatectomy. Methods From a prospective database, 214 consecutive patients who received preoperative systemic chemotherapy (fluoropyrimidine with irinotecan or oxaliplatin) followed by planned one- or two-stage hepatectomy were retrospectively analyzed (1998–2006). In patients undergoing two-stage procedures, minor hepatectomy (wedge or segmental resection[s]) was systematically performed before major (more than three segments), second-stage hepatectomy. Preoperative portal vein embolization (PVE) was performed if indicated. Results One- (group I) and two-stage(group II) hepatectomies were performed in 184 and 21 patients, respectively. Median number of metastases in groups I and II were two (range 1–20) and seven (range 2–20). All patients in group II had bilateral disease vs 39% in group I. Major hepatectomy was performed in all patients in group II and 79% in group I. PVE was performed in 18 group I and 12 group II patients without increase in morbidity. For group I, group II first stage, and group II second stage, respectively, morbidity (24%, 24%, 43%), median hospital stay (7 days, 6 days, 6.5 days) and 30 days postoperative mortality (2%, 0%, 0%) were not significantly different (P = NS). Median follow-up was 25 months; median survival has not been reached. One- and 3-year overall and disease-free survival rates from the time of hepatic resection were 95% and 75%, 63% and 39%, respectively in group I; 95% and 86%, 70% and 51%, respectively in group II (P = NS). Conclusions Two-stage hepatectomy with preoperative chemotherapy results in comparable morbidity and survival rates as one-stage hepatectomy. This approach enables selection and treatment of patients with multiple, bilateral CLM who will benefit from aggressive surgery with good outcomes.PublishedN/A2015-11-12T13:31:22Z2015-11-12T13:31:22Z20072015-11-12Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1091-255Xhttp://hdl.handle.net/10725/2555http://dx.doi.org/10.1007/s11605-007-0272-2Chun, Y. S., Vauthey, J. N., Ribero, D., Donadon, M., Mullen, J. T., Eng, C., ... & Abdalla, E. K. (2007). Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. Journal of Gastrointestinal Surgery, 11(11), 1498-1505.http://link.springer.com/article/10.1007/s11605-007-0272-2enJournal of Gastrointestinal Surgeryinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/25552019-02-26T11:14:01Z
spellingShingle Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases
Chun, Yun Shin
status_str publishedVersion
title Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases
title_full Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases
title_fullStr Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases
title_full_unstemmed Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases
title_short Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases
title_sort Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases
url http://hdl.handle.net/10725/2555
http://dx.doi.org/10.1007/s11605-007-0272-2
http://link.springer.com/article/10.1007/s11605-007-0272-2